NZX assessing further complaint over Grant Samuel's Abano report

The NZX has confirmed it is assessing a second complaint lodged in relation to a Grant Samuel valuation report commissioned by medical investor Abano Healthcare [NZX: ABA].

The issue is one of many that rebel shareholders Peter Hutson and James Reeves are pushing in their bid to oust chairman Trevor Janes.


Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login